Trials / Unknown
UnknownNCT03579862
Identification of Heritable CTEPH
Identification and Molecular Characterization of Heritable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 260 (estimated)
- Sponsor
- Intermountain Health Care, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Some patients who have blood clots come down with a life-threatening condition known as Chronic Thromboembolic Pulmonary Hypertension (CTEPH), which is high blood pressure only in the arteries of the lungs. This study seeks to understand more about the genetics causes of CTEPH by obtaining blood samples and examining family histories.
Detailed description
This project proposes to identify a cohort of Utah patients with CTEPH, and to perform a comprehensive analysis of family history and CTEPH risk factors in these patients, and in controls with acute pulmonary embolism (PE) and pulmonary arterial hypertension (PAH). Detailed family history interviews will be performed with all patients, and all enrolled patients will provide a blood sample for thrombophilia testing and for gene sequencing with the goal of identifying novel genetic variants that contribute to CTEPH risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Draw |
Timeline
- Start date
- 2013-12-25
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2018-07-09
- Last updated
- 2022-10-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03579862. Inclusion in this directory is not an endorsement.